Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METHOTREXATE Cause Product dose omission in error? 52 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 52 reports of Product dose omission in error have been filed in association with METHOTREXATE (Methotrexate). This represents 0.0% of all adverse event reports for METHOTREXATE.

52
Reports of Product dose omission in error with METHOTREXATE
0.0%
of all METHOTREXATE reports
0
Deaths
2
Hospitalizations

How Dangerous Is Product dose omission in error From METHOTREXATE?

Of the 52 reports, 2 (3.8%) required hospitalization, and 1 (1.9%) were considered life-threatening.

Is Product dose omission in error Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METHOTREXATE. However, 52 reports have been filed with the FAERS database.

What Other Side Effects Does METHOTREXATE Cause?

Drug ineffective (70,142) Rheumatoid arthritis (29,254) Off label use (24,020) Pain (23,773) Drug intolerance (22,555) Arthralgia (21,831) Fatigue (19,885) Nausea (18,715) Joint swelling (17,657) Drug hypersensitivity (16,677)

What Other Drugs Cause Product dose omission in error?

DUPILUMAB (7,586) TOFACITINIB (2,461) LENALIDOMIDE (618) PALBOCICLIB (592) DIROXIMEL (481) ABALOPARATIDE (457) NIRAPARIB (428) RUXOLITINIB (425) TERIFLUNOMIDE (371) DIMETHYL (308)

Which METHOTREXATE Alternatives Have Lower Product dose omission in error Risk?

METHOTREXATE vs METHOXSALEN METHOTREXATE vs METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA METHOTREXATE vs METHYL ALCOHOL METHOTREXATE vs METHYLCOBALAMIN METHOTREXATE vs METHYLDOPA

Related Pages

METHOTREXATE Full Profile All Product dose omission in error Reports All Drugs Causing Product dose omission in error METHOTREXATE Demographics